glutamic acid and Thyroid Cancer, Anaplastic

glutamic acid has been researched along with Thyroid Cancer, Anaplastic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bishop, J; Du, J; El-Naggar, AK; Liu, R; Liu, X; Luo, Y; Qu, S; Shan, Z; Shi, X; Sun, H; Teng, W; Wang, E; Xing, M; Yang, X; Zhao, J; Zhu, G1
Hodin, R; Lawler, J; Nucera, C; Parangi, S1

Reviews

1 review(s) available for glutamic acid and Thyroid Cancer, Anaplastic

ArticleYear
The BRAFV600E mutation: what is it really orchestrating in thyroid cancer?
    Oncotarget, 2010, Volume: 1, Issue:8

    Topics: Amino Acid Substitution; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; Cell Transformation, Neoplastic; Glutamic Acid; Humans; Models, Biological; Mutation, Missense; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Valine

2010

Other Studies

1 other study(ies) available for glutamic acid and Thyroid Cancer, Anaplastic

ArticleYear
Association of TERT promoter mutation 1,295,228 C>T with BRAF V600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer.
    The Journal of clinical endocrinology and metabolism, 2015, Volume: 100, Issue:4

    Topics: Age Factors; Aged; Aged, 80 and over; Amino Acid Substitution; Epistasis, Genetic; Female; Genetic Association Studies; Glutamic Acid; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Proto-Oncogene Proteins B-raf; Telomerase; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Valine

2015